In contrast, the mRNA levels of tumor suppress genes (PTEN, BAK, and CDH1) were increased significantly after the blocking of ARPC2, which indicated that ARPC2 downregulated them (Figure 3(b)). This evidence concerns the gene ARPC2 and neoplasm.